KEVIN FORREST

Profile

First Name

: KEVIN

Middle Name

:

Last Name

: FORREST

Related Companies
Titles
Company Name
Related People
DIRECTOR
VARIATION BIOTECHNOLOGIES (US), INC.
DAVID E. ANDERSON, JEFF BAXTER, ADAM BUCKLEY, STEPHEN GILLIS, STEVE GILLIS, STEVEN GILLIS, MARC J. KIRCHMEIER, JEFFREY LEIDEN, EGIDIO NASCIMENTO, SCOTT ROCKLAGE, MICHAEL STEINMETZ, STEVE VIGNAU, STEVEN VIGNAU
EXECUTIVE OFFICER
K2 THERAPEUTICS, INC.
NEIL ABDOLLAHIAN, KEN BARTIZAL, BONNIE BASSLER, PH.D., DAN BURGESS, DANIEL D BURGESS, DANIEL D. BURGESS, CARIN CANALE-THEAKSTON, PAUL DARUWALA, STEVE ELMS, TIMOTHY R FRANSON, DAVID GOLLAHER, PATRICK HERON, KEVIN JUDICE, NINA KJELLSON, JAMES LEVINE, JAMES MERSON, PH.D., CHRYSA MINEO, JESSICA OIEN, MATTHEW ONAITIS, ROBERT J PEREZ, SCOTT ROCKLAGE, SCOTT M ROCKLAGE, TAYLOR SANDISON, TAYLOR SANDISON, M.D., TED SCHROEDER, THEODORE R SCHROEDER, THEODORE R. SCHROEDER, PREETAM SHAH, PH.D., RYAN SPENCER, JEFFREY STEIN, JEFFREY STEIN, PH.D., LAURA TADVALKAR, PH.D., LESLIE TARI, PH.D., DIRK THYE, SHANE WARD
EXECUTIVE OFFICER
CIDARA THERAPEUTICS, INC.
NEIL ABDOLLAHIAN, KEN BARTIZAL, BONNIE BASSLER, PH.D., DAN BURGESS, DANIEL D BURGESS, DANIEL D. BURGESS, CARIN CANALE-THEAKSTON, PAUL DARUWALA, STEVE ELMS, TIMOTHY R FRANSON, DAVID GOLLAHER, PATRICK HERON, KEVIN JUDICE, NINA KJELLSON, JAMES LEVINE, JAMES MERSON, PH.D., CHRYSA MINEO, JESSICA OIEN, MATTHEW ONAITIS, ROBERT J PEREZ, SCOTT ROCKLAGE, SCOTT M ROCKLAGE, TAYLOR SANDISON, TAYLOR SANDISON, M.D., TED SCHROEDER, THEODORE R SCHROEDER, THEODORE R. SCHROEDER, PREETAM SHAH, PH.D., RYAN SPENCER, JEFFREY STEIN, JEFFREY STEIN, PH.D., LAURA TADVALKAR, PH.D., LESLIE TARI, PH.D., DIRK THYE, SHANE WARD
EXECUTIVE OFFICER, DIRECTOR
EXPANSION THERAPEUTICS, INC.
MATTHEW DISNEY, MATTHEW DISNEY, PH.D., KEVIN FORREST, PH.D., JASON HAFLER, JASON HAFLER, PH.D., YUJIRO HATA, YUJIRO HATA, M.B.A., CAMPBELL MURRAY, M.B.B.S., M.B.A., ANDY PHILLIPS, PH.D., SCOTT ROCKLAGE, SCOTT ROCKLAGE, PH.D., BETH SEIDENBERG, M.D., RENATO SKERLJ, PH.D., PAUL STONE, LAURA TADVALKAR, PH.D.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-10-31
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-10-24 
2017-06-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-11-28 
2016-12-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-11-28 
2015-02-17
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-02-10 
2014-06-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-30 
2014-06-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-30 
2014-03-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-03-10 
2013-12-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-09-30 
2013-09-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-08-26 
2013-06-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-06-10 
2013-03-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-02-22